EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High Diagnosis Rate for Nonimmune Hydrops Fetalis With Prenatal Clinical Genome: Expanded Results From the Hydrops‐Yielding Diagnostic Results of Prenatal Sequencing ( HYDROPS ) Study

Stephanie M Rice iD, Mona M Makhamreh iD, Sascha Wodoslawsky iD, Mariella Toro iD, Elizabeth Critchlow iD, Brandy Firman iD, Ruby Liu iD, Babi Ramesh Nallamilli iD, Madhuri Hegde, Seth I Berger iD, Huda B Al-Kouatly iD

American Journal of Medical Genetics Part A · 20.08.2026

DOI: 10.1002/ajmg.a.70265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 20.08.2026. Verfasst von Stephanie M Rice und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal-Fetal Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonimmune hydrops fetalis (NIHF) is characterized by abnormal fluid accumulation in ≥ 2 fetal compartments and may be genetic. The incremental diagnostic yield of prenatal exome sequencing (ES) for NIHF following a negative standard workup was previously explored on 22 cases. We report ES findings in the remaining cohort and investigate the incremental yield of genome sequencing (GS) in cases without a definitive diagnosis from exome. Enrollment criteria and exome methodology for the Hydrops‐Yielding Diagnostic Results of Prenatal Sequencing (HYDROPS) study were previously reported. Exomes without a definitive diagnosis were reviewed with updated clinical information and had GS if DNA was available. A genetic counselor returned the clinical reports. Overall, 50 exomes yielded 22 (44%) diagnoses and six possible diagnoses (12%). Nine new cases (9/28, 68%) had a diagnosis involving one of the following genes: RIT1, SOS1, RYR1, FLT4, LMOD2, KMT2D, PUF60, and BLTP1 . Two additional cases were diagnosed upon reclassification of uncertain variants. GS of eligible ES cases resulted in an incremental diagnostic yield of 7% (1/14). ES and GS in NIHF significantly reduce the number of unexplained cases and guide clinical management and recurrence risks. Currently, the incremental diagnostic yield of GS over ES in NIHF remains under investigation. Trial Registration ClinicalTrials.gov identifier: NCT03911531

Schlagwörter

Stichwörter der Autor:innen

non‐immune hydrops fetalisprenatal exome sequencingprenatal genome sequencing

Autor:innen und Institutionen

  • Division of Maternal-Fetal Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Division of Maternal-Fetal Medicine/Genetics, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, USA.
  • Department of Obstetrics and Gynecology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Obstetrics and Gynecology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Stephanie M Rice, Mona M Makhamreh, Sascha Wodoslawsky, Mariella Toro, Elizabeth Critchlow, Brandy Firman, Ruby Liu, Babi Ramesh Nallamilli, Seth I Berger, Huda B Al-Kouatly

Zitieren

APA

Rice, S. M., Makhamreh, M. M., Wodoslawsky, S., Toro, M., Critchlow, E., Firman, B., Liu, R., Nallamilli, B. R., Hegde, M., Berger, S. I., & Al-Kouatly, H. B. (2026). High Diagnosis Rate for Nonimmune Hydrops Fetalis With Prenatal Clinical Genome: Expanded Results From the Hydrops‐Yielding Diagnostic Results of Prenatal Sequencing ( HYDROPS ) Study. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.70265

Vancouver

Rice SM, Makhamreh MM, Wodoslawsky S, Toro M, Critchlow E, Firman B, et al. High Diagnosis Rate for Nonimmune Hydrops Fetalis With Prenatal Clinical Genome: Expanded Results From the Hydrops‐Yielding Diagnostic Results of Prenatal Sequencing ( HYDROPS ) Study. American Journal of Medical Genetics Part A. 2026. doi:10.1002/ajmg.a.70265

BibTeX
@article{Rice2026,
  author = {Rice, Stephanie M and Makhamreh, Mona M and Wodoslawsky, Sascha and Toro, Mariella and Critchlow, Elizabeth and Firman, Brandy and Liu, Ruby and Nallamilli, Babi Ramesh and Hegde, Madhuri and Berger, Seth I and Al-Kouatly, Huda B},
  title = {High Diagnosis Rate for Nonimmune Hydrops Fetalis With Prenatal Clinical Genome: Expanded Results From the Hydrops‐Yielding Diagnostic Results of Prenatal Sequencing ( HYDROPS ) Study},
  journal = {American Journal of Medical Genetics Part A},
  year = {2026},
  doi = {10.1002/ajmg.a.70265}
}
Kostenlos starten →